MAGL-IN-14
MAGL-IN-14 (compound 2) is a potent inhibitor of MAGL, with IC50 of 0.00289 μM and 0.002 μM in HEK293 and PC3 cells, respectively[1].
Product Specifications
CAS Number
2770967-04-7
UNSPSC
12352005
Target
MAGL
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/magl-in-14.html
Solubility
10 mM in DMSO
Smiles
O=C([C@H]1CC12CCN(C(OC(C(F)(F)F)C(F)(F)F)=O)CC2)NC3=CC=CN=C3
Molecular Formula
C17H17F6N3O3
Molecular Weight
425.33
References & Citations
[1]H. Lundbeck A/S. Preparation of ubstituted 1,1,1,3,3,3-hexafluoropropan-2-yl 6-azaspiro[2.5]octane-6-carboxylates as MAGL inhibitors. World Intellectual Property Organization, WO2022101412 A1 2022-05-19.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402290-100 1x 100 µL
CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) (CFTR/2290R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
![KCTD9 Mouse Monoclonal Antibody [Clone ID: OTI5F11]](https://cdn.genprice.uk/products/937/68dd18b9061270361e90813c/imageurl/cf807663.webp)
CF807663 100 µg
KCTD9 Mouse Monoclonal Antibody [Clone ID: OTI5F11]
Sign In for Pricing
View Details 
BNC880195-100 1x 100 µL
CD66 (CEA) (C66/195), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details